Shares of Axsome Therapeutics Inc. (AXSM) have had a massive rally over the last two months, gaining as much as 177 percent, thanks to positive results of the Company's phase II narcolepsy trial and phase III major depressive disorder trial, announced last December.
from RTT - Biotech https://ift.tt/2wH2WM7
via IFTTT
No comments:
Post a Comment